MARKET

AFFY

AFFY

Affymax
EXMKT
0.0008
NaN%
Opening 09:30 01/20 EST
OPEN
--
PREV CLOSE
0.0026
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0026
52 WEEK LOW
0.0007
MARKET CAP
29.99K
P/E (TTM)
0.011
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AFFY last week (0908-0912)?
Weekly Report · 09/15/2025 10:39
Weekly Report: what happened at AFFY last week (0901-0905)?
Weekly Report · 09/08/2025 10:41
Weekly Report: what happened at AFFY last week (0825-0829)?
Weekly Report · 09/01/2025 10:37
Weekly Report: what happened at AFFY last week (0818-0822)?
Weekly Report · 08/25/2025 10:45
Weekly Report: what happened at AFFY last week (0811-0815)?
Weekly Report · 08/18/2025 10:40
Weekly Report: what happened at AFFY last week (0804-0808)?
Weekly Report · 08/11/2025 10:45
Weekly Report: what happened at AFFY last week (0728-0801)?
Weekly Report · 08/04/2025 10:47
Weekly Report: what happened at AFFY last week (0721-0725)?
Weekly Report · 07/28/2025 10:48
More
About AFFY
Affymax, Inc. is a biopharmaceutical company. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The Company has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.

Webull offers Affymax Inc stock information, including EXMKT: AFFY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AFFY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AFFY stock methods without spending real money on the virtual paper trading platform.